Table 2 Correlation analysis for cholesterol efflux capacity (nā€‰=ā€‰250).

From: Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages

Ā 

r

P

Age

āˆ’0.200

0.002

Body mass index

āˆ’0.115

0.070

Waist circumference

āˆ’0.122

0.055

Systolic blood pressure

āˆ’0.169

0.007

Diastolic blood pressure

āˆ’0.045

0.481

Pulse rate

0.071

0.274

Total cholesterol

0.261

<0.001

LDL cholesterol

āˆ’0.035

0.578

HDL cholesterol

0.580

<0.001

log Triglycerides

āˆ’0.231

<0.001

log Fasting glucose

āˆ’0.148

0.020

log Insulin

āˆ’0.190

0.003

log HOMA-R

āˆ’0.203

0.001

HbA1c

āˆ’0.134

0.035

Blood urea nitrogen

āˆ’0.039

0.537

Creatinine

āˆ’0.107

0.091

eGFR

0.109

0.085

Uric acid

0.001

0.991

log AST

0.146

0.021

log ALT

0.078

0.217

log Ī³GTP

0.050

0.429

log BNP

āˆ’0.151

0.017

log hsCRP

āˆ’0.262

<0.001

log FABP4

āˆ’0.004

0.945

log FABP5

āˆ’0.216

<0.001

  1. AST, Aspartate transaminase; ALT, Alanine transaminase.
  2. BNP, brain natriuretic peptide; eGFR, estimated glomerular filtration rate.
  3. FABP4, fatty acid-binding protein 4; FABP5, fatty acid-binding protein 5.
  4. Ī³GTP, Ī³-glutamyl transpeptidase; hsCRP, high-sensitivity C-reactive protein.
Back to article page